Latest Breaking News On - Winter clinical - Page 1 : comparemela.com

2-GEP test rules out melanoma in real-world study

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditionsIntroduces recurring revenue model for the SRT-100 Vision™ to.

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditionsIntroduces rec.

Dermatology Month in Review: January 2024

January’s Dermatology Month in Review features 2 major FDA decisions, positive results on a new assessment tool, an evaluation of climate change’s impact on eczema, and more.

Jennifer Soung, MD: Findings on Guselkumab for Psoriasis Among Patients with Diverse Skin Types

In this discussion, Soung discusses the VISIBLE study results on guselkumab and its design for individuals of diverse skin tones.